Back
SELLAS Life Sciences Group 10K Form
Sell
44
SLS
SELLAS Life Sciences Group
Last Price:
$1.49
Seasonality Move:
-26.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SLS News And Ratings
See the #1 stock for the next 7 days that we like better than SLS
SLS Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-9.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.31 |
| Price / Book: | 5.39 |
Profitability
| EPS (TTM): | -0.38000 |
|---|---|
| Net Income (TTM): | $-27.1M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
SELLAS Life Sciences Group Earnings Forecast
Key SELLAS Life Sciences Group Financial Ratios
-
The Selling, General & Administrative Expenses for SLS have been equal to 1,258.20% of Gross Profit Margin.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
SELLAS Life Sciences Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SLS |
| CUSIP: | 81642T |
| Website: | sellaslifesciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLS Technical Analysis vs Fundamental Analysis
Sell
44
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy or a Sell?
-
SELLAS Life Sciences Group stock is rated a SellThe current SELLAS Life Sciences Group [SLS] share price is $1.50. The Score for SLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.